Oncology research news from Australia and around the world
A novel radiopharmaceutical therapy approach that targets fibroblast activation protein (FAP)—which is highly expressed on…
Cancer risk increases with age and is often more aggressive and difficult to treat in…
A phase 1b trial combining a bispecific T cell engager with a tumour-targeted costimulatory agent…
For over a decade, a class of drugs called BET inhibitors has been tested in…
Breast Cancer Trials’ new clinical breast cancer trial, named ROSALIE, aims to discover whether people…
One of oncology’s biggest challenges is that the same treatment can work well for some…
Researchers have identified a protein linked to an increased risk of metastasis and recurrence in…
Two new studies challenge a decades-old assumption that the thymus, an organ best known for…
A new editorial published in JAMA Oncology warns that cancer care progress is under threat from a…
The Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo’s São Carlos Institute…